Anti-CTLA-4 therapy in bladder cancer patients alters immune responses by increasing IFNγ production and decreasing the CD4+FOXP3 + regulatory T cells in the tumor microenvironment

Ch I. Liakou, A. Kamat, D. Ng Tang, H. Chen, J. Sun, Ch Logothetis, P. Sharma

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Anti-CTLA-4 therapy in bladder cancer patients alters immune responses by increasing IFNγ production and decreasing the CD4+FOXP3 + regulatory T cells in the tumor microenvironment'. Together they form a unique fingerprint.

Medicine & Life Sciences